Research

A Secondary Analysis of a Randomized Clinical Trial

Using Medicare claims, Schaeffer experts documented US prescribing patterns for originator biologic trastuzumab (Herceptin), a targeted cancer therapy, and five biosimilar entrants since 2019.

Noncitizens experience a high burden of cost-related barriers to prescription medications.

Food insecure households with low head-of-household education, and at least one household member with type 2 diabetes, had the highest risk of SARS-CoV-2.

Americans have benefited substantially from new medical treatments, and the United States serves as the engine of medical innovation for the world.

Despite efforts to address the opioid crisis, opioid-related overdoses remain a significant contributor to mortality.

The national hepatitis C elimination initiative would substantially reduce HCV-related morbidity and mortality and would reduce healthcare spending at 10 years and beyond.

Providing primary care clinicians with suitable assessment tools, integrating brief cognitive assessments into routine workflows, and crafting payment policies to encourage adoption of assessments would all help improve detection.

The cumulative social benefits from Medicare coverage for new obesity treatments over the next 10 years would reach almost $1 trillion, or roughly $100 billion per year.

Parents’ perceptions of the COVID-19 vaccine’s long-term comparative risk and their greater anticipated responsibility for children getting sick if vaccinated (versus not) were associated with lower vaccine uptake among children of vaccinated parents.